Studies on the site of renal salt loss in a patient with Bartter's syndrome.
D000293:Adolescent; D000328:Adult; D000471:Alkalosis / Q000209:etiology; D000804:Angiotensin II / Q000494:pharmacology; D001693:Biological Transport, Active; D001794:Blood Pressure / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D002740:Chlorothiazide / Q000494:pharmacology; D005919:Glomerular Filtration Rate; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D006929:Hyperaldosteronism / Q000209:etiology*; D006965:Hyperplasia / Q000473:pathology; D006984:Hypertrophy / Q000209:etiology; D007008:Hypokalemia / Q000209:etiology; D007444:Inulin; D007606:Juxtaglomerular Apparatus / Q000473:pathology*; D007674:Kidney Diseases / Q000503:physiopathology*; D007677:Kidney Function Tests; D007686:Kidney Tubules, Distal / Q000503:physiopathology; D008138:Loop of Henle / Q000378:metabolism; D008297:Male; D009318:Natriuresis; D012964:Sodium / Q000378:metabolism; D013577:Syndrome
D000804:Angiotensin II; D002740:Chlorothiazide; D007444:Inulin; D012964:Sodium